ARYLSULFATASE
B
DEFICIENCY
IN
MAROTEAUXLAMY
SYNDROME
CELLULAR
STUDIES
AND
CARRIER
IDENTIFICATION
ARYLSULFATASE
B
DEFICIENCY
WAS
DEMONSTRATED
IN
PERIPHERAL
LEUKOCYTES
CULTURED
SKIN
FIBROBLASTS
AND
A
LYMPHOID
LINE
DERIVED
FROM
A
PATIENT
WITH
MLS
THE
PATIENTS
PARENTS
DEMONSTRATED
LEVELS
OF
ARYLSULFATASE
B
THAT
WERE
INTERMEDIATE
BETWEEN
THOSE
FOUND
IN
PATIENT
AND
THOSE
IN
CONTROL
SUBJECTS
THE
ACTIVITY
MEAN
PLUS
OR
MINUS
SD
IN
LEUKOCYTES
FROM
NORMAL
SUBJECTS
THE
PATIENTS
PARENTS
AND
THE
PATIENT
WAS
1137
PLUS
OR
MINUS
362
310
AND
52
NMOL
4NITROCATECHOLMG
PROTEINHR
RESPECTIVELY
IN
SKIN
FIBROBLASTS
OF
THE
SAME
SUBJECTS
THE
ACTIVITY
WAS
1452
PLUS
OR
MINUS
416
585
AND
70
RESPECTIVELY
NINE
OTHER
LYSOSOMAL
ENZYMES
WERE
NORMAL
IN
SKIN
FIBROBLASTS
OF
THE
PATIENT
NO
ARYLSULFATASE
B
ACTIVITY
WAS
DETECTED
IN
A
LYMPHOID
LINE
ESTABLISHED
FROM
THE
PATIENT
WITH
MLS
THE
ARYLSULFATASE
B
ACTIVITY
IN
CULTURED
AMNIOTIC
FLUID
CELLS
FROM
10
NORMAL
PREGNANCIES
WAS
2032
PLUS
OR
MINUS
499
